Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Danish drugmaker Novo Nordisk presented its annual report in Bagsvaerd, Denmark, showcasing flags with the company's logos, including those of ...
Saturday, May 31, 2025
Tag: Nordisk039s
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Novo Nordisk's hopes of revolutionizing obesity treatment with its CagriSema drug have been cast into doubt following disappointing trial results, ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.